EU · Liquidity

Two tools aren’t enough: LMT calibration before 16 April 2027

Most funds have already selected their liquidity management tools. The harder part, calibrating and evidencing them, is due for existing UCITS and open-ended AIFs by April 2027. Here is what that involves and a timetable for getting there.

In brief

  • Every EU UCITS and open-ended AIF must select at least two liquidity management tools from a harmonised list. That obligation has applied since 16 April 2026.
  • Funds that existed before that date have until 16 April 2027 to meet the detailed rules on how those tools are defined, calibrated and activated.
  • Calibration is quantitative work. It needs transaction cost estimates, liquidity stress testing and investor data, and it usually ends in a prospectus change that needs regulatory approval.
  • For most small funds, that means starting now.

The revisions to the UCITS Directive and the AIFMD made liquidity management tools a standard feature of every open-ended fund in the EU. Many managers dealt with the first step in early 2026 by adding two tools to their fund documents. The harder step, deciding exactly how those tools would work and proving the settings are right, is due by April 2027 for existing funds.

 

What the rules require

Managers of UCITS and open-ended AIFs must select at least two tools from a defined list:

  • Quantitative tools, which limit or delay redemptions: redemption gates and extension of notice periods.
  • Anti-dilution tools, which pass the cost of dealing to the investors who cause it: redemption fees, swing pricing, dual pricing and anti-dilution levies.
  • Redemption in kind, where investors receive assets rather than cash.

Suspension of dealing and side pockets remain available in exceptional circumstances, but they do not count towards the two. Selecting only swing pricing and dual pricing together does not satisfy the requirement either. Money market funds need only one tool.

ESMA’s guidelines add that managers should consider the merits of choosing at least one quantitative tool and at least one anti-dilution tool, so that a fund can both manage the pace of outflows and protect remaining investors from their cost. The final choice remains the manager’s responsibility, but a fund that departs from that pattern should be able to explain why.

 

Where the work is: calibration

Selection is a policy decision. Calibration is analysis. For each selected tool, the manager has to set parameters that fit the fund’s strategy, assets, dealing frequency and investors, and be able to show a regulator how they were set.

ToolWhat must be calibratedEvidence you will need
Redemption gateThe activation threshold (for UCITS, as a percentage of NAV and at fund level), and how unmet requests are carried forwardHistorical flow data, liquidity stress test results, asset liquidity profile
Extension of notice periodThe length of the extension and the conditions for applying itTime to liquidate under stress, dealing and settlement cycle
Swing pricingThe activation threshold, the swing factor and a maximum factorTransaction cost estimates by asset type, including implicit costs such as spreads
Anti-dilution levy or redemption feeThe level or range of the charge and when it appliesExplicit and implicit dealing costs, and market impact where it is significant
Redemption in kindWhich investors and circumstances it can apply to, and how assets are allocatedInvestor base analysis, fair allocation methodology

Two features run through all of this. First, anti-dilution tools should reflect real costs, including implicit ones such as bid-offer spreads, not a round number chosen for convenience. Second, thresholds should take account of how often the fund prices, how liquid its assets are and who its investors are. A daily-dealing fund with a few large nominee holders needs different settings from a monthly fund with many small investors.

 

Governance and disclosure

The selected tools, and the conditions for using them, must be documented in an LMT policy that sits within the fund’s liquidity risk management process. Investors must be told which tools the fund can use and what they mean for costs and access to their money. For most funds, that means amending the prospectus or offering document, and, for authorised funds, having those changes approved. That approval step is what makes April 2027 closer than it looks.

When a tool is activated or deactivated, the decision and its basis need to be recorded. Where a fund uses swing pricing and applies a factor above its stated maximum, it should be able to justify that afterwards if asked.

 

A practical timetable for a small fund

  1. October to November 2026: gather the data. Collect two to three years of subscription and redemption history, investor concentration data, and transaction cost estimates for each asset type the fund holds.
  2. November to December 2026: run the analysis. Link liquidity stress test results to candidate thresholds. Back-test the proposed settings against past flows to see when they would have triggered.
  3. January 2027: board approval. Present the analysis, approve the LMT policy and calibrations, and minute the reasoning.
  4. February to March 2027: documents and filings. Update the prospectus and investor disclosures, and submit changes for approval where required. Brief the administrator on operational procedures.
  5. By 16 April 2027: go live. Operate the tools, monitor them in the monthly risk report, and review the calibration at least annually.

 

What good evidence looks like

If a regulator asks why a gate is set at a particular level, the answer should be a short file, not a recollection. That file should contain the data used, the stress test results, the cost estimates, the back-test of the proposed thresholds, the board minutes approving them and the resulting disclosure. Built once, it becomes the baseline for each annual review.

For boards, the monthly risk report is where this becomes visible: which tools are available, where the fund stands against each threshold, and whether any were close to activation. A report that still lists LMTs as “to be confirmed” in 2027 will be difficult to defend.

Sources

  • Directive (EU) 2024/927 amending the AIFMD and the UCITS Directive.
  • Commission Delegated Regulations (EU) 2026/465 (AIFs) and 2026/466 (UCITS) on the characteristics of liquidity management tools.
  • ESMA, Guidelines on liquidity management tools of UCITS and open-ended AIFs (ESMA34-671404336-1364).
  • ESMA, Guidelines on liquidity stress testing in UCITS and AIFs.

This article is for professional investors, fund boards and service providers. It is a general commentary, not legal, regulatory or investment advice, and does not reproduce the full text of any regulatory document; readers should refer to the source documents and take their own advice. ACM Europe Limited, trading as Navigate Portfolio Advisers, is authorised and regulated by the Malta Financial Services Authority. Company number C 26673. Registered office: Nu Bis Centre, Mosta Road, Lija LJA 9012, Malta.

Independent risk management for UCITS and AIFs

An MFSA-approved risk function and a monthly board pack, priced per sub-fund.

Book a gap review
Request a sample report

READ MORE

Related Content

Ready To Work With Us?

Partner with a team that sees beyond the market noise.